Heterogeneity of Zika virus exposure and outcome ascertainment across cohorts of pregnant women, their infants and their children: a metadata survey

Abstract

ObjectivesTo support the Zika virus (ZIKV) Individual Participant Data (IPD) Consortium’s efforts to harmonise and analyse IPD from ZIKV-related prospective cohort studies and surveillance-based studies of pregnant women and their infants and children; we developed and disseminated a metadata survey among ZIKV-IPD Meta-Analysis (MA) study participants to identify and provide a comprehensive overview of study-level heterogeneity in exposure, outcome and covariate ascertainment and definitions.SettingCohort and surveillance studies that measured ZIKV infection during pregnancy or at birth and measured fetal, infant, or child outcomes were identified through a systematic search and consultations with ZIKV researchers and Ministries of Health from 20 countries or territories.ParticipantsFifty-four cohort or active surveillance studies shared deidentified data for the IPD-MA and completed the metadata survey, representing 33 061 women (11 020 with ZIKV) and 18 281 children.Primary and secondary outcome measuresStudy-level heterogeneity in exposure, outcome and covariate ascertainment and definitions.ResultsMedian study sample size was 268 (IQR=100, 698). Inclusion criteria, follow-up procedures and exposure and outcome ascertainment were highly heterogenous, differing meaningfully across regions and multisite studies. Enrolment duration and follow-up for children after birth varied before and after the declaration of the Public Health Emergency of International Concern (PHEIC) and according to the type of funding received.ConclusionThis work highlights the logistic and statistical challenges that must be addressed to account for the multiple sources of within-study and between-study heterogeneity when conducting IPD-MAs of data collected in the research response to emergent pathogens like ZIKV.

Building a growing genomic data repository for maternal and fetal health through the PING Consortium

“…As the data collection protocols varied in each study, creating a centralized database that both compartmentalizes each site’s information and integrates data across the entire study became crucial for data analysis. 50 To harmonize the data, we designed an iterative four-step process to integrate clinical, laboratory, and radiological data into a single database where information is harmonized and interpretable for the cohort as a whole (Figure 3). We began by reviewing the data obtained from each site to identify overlapping variables.…”

Clinical spectrum of congenital Zika virus infection in Brazil: Update and issues for research development

“…A comprehensive metadata survey of 54 cohorts of Zika infected pregnant women supported by the WHO initiative showed heterogeneity in exposure and outcome ascertainment across the studies. This variability may be due to the lack of standard protocols and evolving knowledge in this field, considering the novelty of congenital disease 86 . Therefore, establishing a consensus on case and exposure definitions and harmonizing the variables across studies was the initial step of a time-consuming process that the researchers still faced to allow IPD-meta-analysis.…”

A systematic review of maternal and perinatal health outcomes in the context of epidemic threats: towards the development of a core outcome set.

“…However, the process of generating relevant scienti c evidence on effects of outbreaks, epidemics and pandemics on maternal and perinatal health generally lags behind [11,12]. Wide variations in how health outcomes are de ned, measured and reported across studies signi cantly limits researchers' ability to compare and interpret ndings and to draw reliable conclusions [13][14][15]. This, in turn, represents a substantial barrier to translating research into public health interventions and clinical practice.…”